147 related articles for article (PubMed ID: 18626197)
1. Gut decontamination with norfloxacin and ampicillin enhances insulin sensitivity in mice.
Chou CJ; Membrez M; Blancher F
Nestle Nutr Workshop Ser Pediatr Program; 2008; 62():127-37; discussion 137-40. PubMed ID: 18626197
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice.
Membrez M; Blancher F; Jaquet M; Bibiloni R; Cani PD; Burcelin RG; Corthesy I; Macé K; Chou CJ
FASEB J; 2008 Jul; 22(7):2416-26. PubMed ID: 18326786
[TBL] [Abstract][Full Text] [Related]
3. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice.
Cani PD; Bibiloni R; Knauf C; Waget A; Neyrinck AM; Delzenne NM; Burcelin R
Diabetes; 2008 Jun; 57(6):1470-81. PubMed ID: 18305141
[TBL] [Abstract][Full Text] [Related]
4. Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?
Esteve E; Ricart W; Fernández-Real JM
Curr Opin Clin Nutr Metab Care; 2011 Sep; 14(5):483-90. PubMed ID: 21681087
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of n-3 polyunsaturated fatty acids on metabolic control and vascular reactivity in the type 2 diabetic ob/ob mouse.
Mustad VA; Demichele S; Huang YS; Mika A; Lubbers N; Berthiaume N; Polakowski J; Zinker B
Metabolism; 2006 Oct; 55(10):1365-74. PubMed ID: 16979408
[TBL] [Abstract][Full Text] [Related]
6. Manipulation of the gut microbiota in C57BL/6 mice changes glucose tolerance without affecting weight development and gut mucosal immunity.
Bech-Nielsen GV; Hansen CH; Hufeldt MR; Nielsen DS; Aasted B; Vogensen FK; Midtvedt T; Hansen AK
Res Vet Sci; 2012 Jun; 92(3):501-8. PubMed ID: 21543097
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic effects of MDG-1, a polysaccharide derived from Ophiopogon japonicas, in the ob/ob mouse model of type 2 diabetes mellitus.
Xu J; Wang Y; Xu DS; Ruan KF; Feng Y; Wang S
Int J Biol Macromol; 2011 Nov; 49(4):657-62. PubMed ID: 21756932
[TBL] [Abstract][Full Text] [Related]
8. Divergent metabolic outcomes arising from targeted manipulation of the gut microbiota in diet-induced obesity.
Murphy EF; Cotter PD; Hogan A; O'Sullivan O; Joyce A; Fouhy F; Clarke SF; Marques TM; O'Toole PW; Stanton C; Quigley EM; Daly C; Ross PR; O'Doherty RM; Shanahan F
Gut; 2013 Feb; 62(2):220-6. PubMed ID: 22345653
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the gut microbiota in leptin deficient obese mice - Correlation to inflammatory and diabetic parameters.
Ellekilde M; Krych L; Hansen CH; Hufeldt MR; Dahl K; Hansen LH; Sørensen SJ; Vogensen FK; Nielsen DS; Hansen AK
Res Vet Sci; 2014 Apr; 96(2):241-50. PubMed ID: 24556473
[TBL] [Abstract][Full Text] [Related]
10. Long-term effect of fish oil diet on basal and stimulated plasma glucose and insulin levels in ob/ob mice.
Steerenberg PA; Beekhof PK; Feskens EJ; Lips CJ; Höppener JW; Beems RB
Diabetes Nutr Metab; 2002 Aug; 15(4):205-14. PubMed ID: 12416657
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-2 receptor modulates islet adaptation to metabolic stress in the ob/ob mouse.
Bahrami J; Longuet C; Baggio LL; Li K; Drucker DJ
Gastroenterology; 2010 Sep; 139(3):857-68. PubMed ID: 20546737
[TBL] [Abstract][Full Text] [Related]
12. Dietary capsaicin reduces obesity-induced insulin resistance and hepatic steatosis in obese mice fed a high-fat diet.
Kang JH; Goto T; Han IS; Kawada T; Kim YM; Yu R
Obesity (Silver Spring); 2010 Apr; 18(4):780-7. PubMed ID: 19798065
[TBL] [Abstract][Full Text] [Related]
13. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes?
Diamant M; Blaak EE; de Vos WM
Obes Rev; 2011 Apr; 12(4):272-81. PubMed ID: 20804522
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice.
Dentin R; Benhamed F; Hainault I; Fauveau V; Foufelle F; Dyck JR; Girard J; Postic C
Diabetes; 2006 Aug; 55(8):2159-70. PubMed ID: 16873678
[TBL] [Abstract][Full Text] [Related]
15. Development of glucose intolerance and impaired plasma insulin response to glucose in obese hyperglycaemic (ob/ob) mice.
Flatt PR; Bailey CJ
Horm Metab Res; 1981 Oct; 13(10):556-60. PubMed ID: 7028589
[TBL] [Abstract][Full Text] [Related]
16. Role of gut microflora in the development of obesity and insulin resistance following high-fat diet feeding.
Cani PD; Delzenne NM; Amar J; Burcelin R
Pathol Biol (Paris); 2008 Jul; 56(5):305-9. PubMed ID: 18178333
[TBL] [Abstract][Full Text] [Related]
17. Antihyperglycaemic effect of saccharin in diabetic ob/ob mice.
Bailey CJ; Day C; Knapper JM; Turner SL; Flatt PR
Br J Pharmacol; 1997 Jan; 120(1):74-8. PubMed ID: 9117102
[TBL] [Abstract][Full Text] [Related]
18. Leptin deficiency per se dictates body composition and insulin action in ob/ob mice.
van den Hoek AM; Teusink B; Voshol PJ; Havekes LM; Romijn JA; Pijl H
J Neuroendocrinol; 2008 Jan; 20(1):120-7. PubMed ID: 18081560
[TBL] [Abstract][Full Text] [Related]
19. In vivo knockdown of p85alpha with an antisense oligonucleotide improves insulin sensitivity in Lep(ob/ob) and diet-induced obese mice.
Moriarty MW; McCurdy CE; Janssen RC; Shaw T; Leitner JW; Friedman JE; Draznin B
Horm Metab Res; 2009 Oct; 41(10):757-61. PubMed ID: 19598077
[TBL] [Abstract][Full Text] [Related]
20. Partial leptin deficiency favors diet-induced obesity and related metabolic disorders in mice.
Begriche K; Lettéron P; Abbey-Toby A; Vadrot N; Robin MA; Bado A; Pessayre D; Fromenty B
Am J Physiol Endocrinol Metab; 2008 May; 294(5):E939-51. PubMed ID: 18349116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
